In silico prioritization and further functional characterization of SPINK1 intronic variants
Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40246-017-0103-9 |
id |
doaj-6d6d431cedb1429eb7ebabe149eacc44 |
---|---|
record_format |
Article |
spelling |
doaj-6d6d431cedb1429eb7ebabe149eacc442020-11-25T00:41:11ZengBMCHuman Genomics1479-73642017-05-011111710.1186/s40246-017-0103-9In silico prioritization and further functional characterization of SPINK1 intronic variantsWen-Bin Zou0Hao Wu1Arnaud Boulling2David N. Cooper3Zhao-Shen Li4Zhuan Liao5Jian-Min Chen6Claude Férec7Department of Gastroenterology, Changhai Hospital, Second Military Medical UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityInstitut National de la Santé et de la Recherche Médicale (INSERM)Institute of Medical Genetics, School of Medicine, Cardiff UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityDepartment of Gastroenterology, Changhai Hospital, Second Military Medical UniversityInstitut National de la Santé et de la Recherche Médicale (INSERM)Institut National de la Santé et de la Recherche Médicale (INSERM)Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of transfected HEK293T cells, we concluded that 24 studied SPINK1 intronic variants were not of pathological significance, the sole exceptions being two canonical splice site variants (i.e., c.87 + 1G > A and c.194 + 2T > C). Herein, we employed the splicing prediction tools included within the Alamut software suite to prioritize the ‘non-pathological’ SPINK1 intronic variants for further quantitative RT-PCR analysis. Results Although our results demonstrated the utility of in silico prediction in classifying and prioritizing intronic variants, we made two observations worth noting. First, we established that most of the prediction tools employed ignored the general rule that GC is a weaker donor splice site than the canonical GT site. This finding is potentially important because for a given disease gene, a GC variant donor splice site may be associated with a milder clinical manifestation. Second, the non-pathological c.194 + 13T > G variant was consistently predicted by different programs to generate a new and viable donor splice site, the prediction scores being comparable to those for the physiological c.194 + 2T donor splice site and even higher than those for the physiological c.87 + 1G donor splice site. We do however provide convincing in vitro evidence that the predicted donor splice site was not entirely spurious. Conclusions Our findings, taken together, serve to emphasize the importance of functional analysis in helping to establish or refute the pathogenicity of specific intronic variants.http://link.springer.com/article/10.1186/s40246-017-0103-9Aberrant mRNA transcriptsChronic pancreatitisIn silicoIntronic variantsNon-canonical splice sitesQuantitative RT-PCR analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wen-Bin Zou Hao Wu Arnaud Boulling David N. Cooper Zhao-Shen Li Zhuan Liao Jian-Min Chen Claude Férec |
spellingShingle |
Wen-Bin Zou Hao Wu Arnaud Boulling David N. Cooper Zhao-Shen Li Zhuan Liao Jian-Min Chen Claude Férec In silico prioritization and further functional characterization of SPINK1 intronic variants Human Genomics Aberrant mRNA transcripts Chronic pancreatitis In silico Intronic variants Non-canonical splice sites Quantitative RT-PCR analysis |
author_facet |
Wen-Bin Zou Hao Wu Arnaud Boulling David N. Cooper Zhao-Shen Li Zhuan Liao Jian-Min Chen Claude Férec |
author_sort |
Wen-Bin Zou |
title |
In silico prioritization and further functional characterization of SPINK1 intronic variants |
title_short |
In silico prioritization and further functional characterization of SPINK1 intronic variants |
title_full |
In silico prioritization and further functional characterization of SPINK1 intronic variants |
title_fullStr |
In silico prioritization and further functional characterization of SPINK1 intronic variants |
title_full_unstemmed |
In silico prioritization and further functional characterization of SPINK1 intronic variants |
title_sort |
in silico prioritization and further functional characterization of spink1 intronic variants |
publisher |
BMC |
series |
Human Genomics |
issn |
1479-7364 |
publishDate |
2017-05-01 |
description |
Abstract Background SPINK1 (serine protease inhibitor, kazal-type, 1), which encodes human pancreatic secretory trypsin inhibitor, is one of the most extensively studied genes underlying chronic pancreatitis. Recently, based upon data from qualitative reverse transcription-PCR (RT-PCR) analyses of transfected HEK293T cells, we concluded that 24 studied SPINK1 intronic variants were not of pathological significance, the sole exceptions being two canonical splice site variants (i.e., c.87 + 1G > A and c.194 + 2T > C). Herein, we employed the splicing prediction tools included within the Alamut software suite to prioritize the ‘non-pathological’ SPINK1 intronic variants for further quantitative RT-PCR analysis. Results Although our results demonstrated the utility of in silico prediction in classifying and prioritizing intronic variants, we made two observations worth noting. First, we established that most of the prediction tools employed ignored the general rule that GC is a weaker donor splice site than the canonical GT site. This finding is potentially important because for a given disease gene, a GC variant donor splice site may be associated with a milder clinical manifestation. Second, the non-pathological c.194 + 13T > G variant was consistently predicted by different programs to generate a new and viable donor splice site, the prediction scores being comparable to those for the physiological c.194 + 2T donor splice site and even higher than those for the physiological c.87 + 1G donor splice site. We do however provide convincing in vitro evidence that the predicted donor splice site was not entirely spurious. Conclusions Our findings, taken together, serve to emphasize the importance of functional analysis in helping to establish or refute the pathogenicity of specific intronic variants. |
topic |
Aberrant mRNA transcripts Chronic pancreatitis In silico Intronic variants Non-canonical splice sites Quantitative RT-PCR analysis |
url |
http://link.springer.com/article/10.1186/s40246-017-0103-9 |
work_keys_str_mv |
AT wenbinzou insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT haowu insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT arnaudboulling insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT davidncooper insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT zhaoshenli insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT zhuanliao insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT jianminchen insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants AT claudeferec insilicoprioritizationandfurtherfunctionalcharacterizationofspink1intronicvariants |
_version_ |
1725286922918559744 |